Clinical data indicate that in a cohort of 2,032 heart failure patients, higher plasma IL-17D concentrations are significantly associated with atrial fibrillation, increased levels of plasma N-terminal brain natriuretic peptide precursor, and poorer prognosis (44). The gene discussed is IL17D; the disease is atrial fibrillation.